Freya Biosciences

We’re thrilled to announce that Colleen Acosta, Freya’s visionary CEO, has been named a finalist for the European Lifestars Awards for Women-Led Business Leader of the Year! This recognition highlights Colleen's dedication to leading with passion, innovation, and an unwavering commitment to excellence. We couldn’t be prouder to stand alongside her on this incredible journey. #LifestarsAwards #Leadership #WomenInBusiness #TeamFreya

Join our CEO, Colleen Acosta, at TechBBQ 2024 (September 11-12). In this session, you'll hear insights from Colleen and representatives of EIFO and Novo Nordisk Foundation on why Denmark is emerging as a leading Life Science Nation, with new initiatives boosting knowledge-based entrepreneurship and innovation districts. 📅 Don't miss out! Check out the full session details and register now: https://lnkd.in/drZzUTxY

Freya will be at the 9th Microbiome Movement in Boston, July 10-12 (https://lnkd.in/ddhHiQJ). Colleen Acosta, Freya’s CEO will give a presentation on Friday, July 12 entitled “Pioneering a New Class of Microbial Immunotherapies for Women’s Health“. Ulrich Binné, CBO, Crilles Casper Larsen, SVP CMC & Quality, and Kevin DeLong, Senior Scientist will also attend. We look forward to seeing our colleagues at the meeting.

Our CSO Johan E.T. van Hylckama Vlieg will be presenting recent clinical data obtained from vaginal microbiota transplants (VMT) without antibiotic pretreatment in women with asymptomatic dysbiosis at the ESHRE annual meeting European Society of Human Reproduction and Embryology (ESHRE) #ESHRE2024 #womenshealth #fertility #reproductivehealth #immunotherapy #microbiome #microbiota

We at Freya have posted a manuscript on https://lnkd.in/gvAGmMV8 describing our clinical trial DYSCOVER-1 investigating vaginal microbiota transplantation (VMT) for successful dysbiosis resolution. Together with a companion paper by Henriette Svarre Nielsen and team these are the first randomized placebo-controlled VMT clinical trials. Both manuscripts are submitted for peer review, but we are making the studies available here now to the scientific community and to our highly engaged study participants, without whom this would not have been possible! #womenshealth #microbiome #microbiota #immunotherapy #worldmicrobiomeday

We are proud to be recognized by Sifted for our innovation! A special thank you to all of our partners who provide us with support so we may continue to deliver groundbreaking work.

Here's to all the incredible mothers—may your day be filled with love, joy, and cherished moments. At Freya Bioscience, we're rewriting the story of maternity. Together, let's redefine what's possible. Happy Mothers Day.

Thanks so much to The Medicine Maker and Stephanie Vine (formerly Sutton) for this feature on our work at Freya Biosciences in developing new therapeutics for women!

We welcome Laura Ensign, one of Freya’s co-founders and our SAB chair to Copenhagen. Click on the link and register: https://lnkd.in/dFk62dU2

Join us in Copenhagen, Denmark, from April 9th to 11th, 2024, for the Microbiomes in Women's Health Congress. Johan van Hylckama Vlieg, our CSO and co-founder is a member of the Organizing Committee. Don't miss this opportunity to network, learn, and contribute to the future of women's health. Freya will be present and looks forward to greeting many of our colleagues and friends in Copenhagen